4-(cyclopropylmethoxy)-N-propyl-2-[2-[[2-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethylamino]acetyl]amino]-4-pyridinyl]-1,3-thiazole-5-carboxamide

InChIKey	`YPWPKJLJKMSERN-UHFFFAOYSA-N`
Compound Name	4-(cyclopropylmethoxy)-N-propyl-2-[2-[[2-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethylamino]acetyl]amino]-4-pyridinyl]-1,3-thiazole-5-carboxamide
Canonical SMILES	`CCCNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	7.33
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P22303	ACHE	Homo sapiens	Human	PF08674 PF00135	8.3	IC50	ChEMBL;BindingDB
P06276	BCHE	Homo sapiens	Human	PF08674 PF00135	7.0	IC50	ChEMBL;BindingDB
P49841	GSK3B	Homo sapiens	Human	PF00069	6.6	IC50	ChEMBL;BindingDB